Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition
Clinical and Experimental Dermatology, 10/30/09
Clayton R et al. – Beta–blockers and NSAIDS are associated with LP, suggesting that withdrawal of these drugs should be considered. Further studies are needed to confirm or refute the inverse relationship between mucosal LP and use of ACE inhibitors.
Related Articles
Update on oral lichen planus
Expert Review of Dermatology, 10/14/09
Relevance Score: 67%
Cyclosporine in the management of esophageal lichen planus
Canadian Journal of Gastroenterology, 10/12/09
Relevance Score: 66%
Lichen planus in childhood: report of 100 cases
Clinical and Experimental Dermatology, 11/10/09
Relevance Score: 65%
Management of Symptomatic Esophageal Involvement With Lichen Planus
Journal of Clinical Gastroenterology, 10/21/09
Relevance Score: 65%
Basement membrane changes in lichen planopilaris
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 42%
Today in Dermatopathology...keeping you current
Receive free subspecialty "5-minute updates" via email
Topical Calcipotriol for Preventive Treatment of Hypertrophic Scars
Archives of Dermatology, 11/25/09
Granulomatous Dermatitis With Pseudoxanthoma Elasticum-Like Changes
Archives of Dermatology, 11/25/09
Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Archives of Dermatology, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


